Skip to main content
Top
Published in: Nutrition Journal 1/2015

Open Access 01-12-2015 | Research

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire

Authors: Nallely Bueno-Hernández, Martha Núñez-Aldana, Ilse Ascaño-Gutierrez, Jesús K Yamamoto-Furusho

Published in: Nutrition Journal | Issue 1/2015

Login to get access

Abstract

Background

Ulcerative Colitis (UC) is a chronic disease characterized by inflammation of colonic mucosa. Environmental factors such as dietary patterns may increase symptoms in UC patients.

Aim

To validate and implement a questionnaire to identify foods that exacerbates symptoms in UC patients.

Methods

A prospective cohort study was conducted to validate and to assess the relationship of food and symptoms in Mexican UC patients.

Results

The IVC obtained was 0.56 in the questionnaire and kappa = 0.03 in foods from animal origin, 0.5 cereals and tubers, 0.2 legumes, 0.4 vegetables and fruits, 0.4 fats and 0.3 in others. The evaluation was carried out in UC patients (n = 233), 65% active and 35% in UC remission, the current age was 45 (SD; 15) years in active UC and 40 (SD; 15) years in UC remission. Three food groups were made based on the frequency of symptoms: Group A; symptoms more often, especially the active vs remission (P <0.05); Group B caused more symptoms in remission UC vs active UC (P = 0.07) and Group C caused more symptoms in the active UC (P = 0.05).

Conclusion

Foods with higher frequency of symptoms in patients with UC were: beans, whole milk, plum, lima beans and spicy sauce.
Literature
2.
go back to reference Kyung M, Young M. Nutritional modulators of ulcerative colitis. Clinical efficacies and mechanistic view. World J Gastroenterol. 2013;19:994–1004.CrossRef Kyung M, Young M. Nutritional modulators of ulcerative colitis. Clinical efficacies and mechanistic view. World J Gastroenterol. 2013;19:994–1004.CrossRef
3.
go back to reference Yamamoto-Furusho JK. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987–2006). J Clin Gastroenterol. 2009;43(3):221–4.CrossRefPubMed Yamamoto-Furusho JK. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987–2006). J Clin Gastroenterol. 2009;43(3):221–4.CrossRefPubMed
4.
go back to reference Albenberg LG, Lewis JD, Wu GD. Food and the gut microbiota in IBD: a critical connection. Curr Opin Gastroenterol. 2012;28(4):1–12.CrossRef Albenberg LG, Lewis JD, Wu GD. Food and the gut microbiota in IBD: a critical connection. Curr Opin Gastroenterol. 2012;28(4):1–12.CrossRef
5.
go back to reference Bueno-Hernández N, Mañe-Almero J, Cortés I, Yamamoto-Furusho JK. Role of nutrition in Inflammatory Bowel Disease (IBD): new therapeutic approaches and recent outcomes. J Nutr Therapeutics. 2012;1:59–73. Bueno-Hernández N, Mañe-Almero J, Cortés I, Yamamoto-Furusho JK. Role of nutrition in Inflammatory Bowel Disease (IBD): new therapeutic approaches and recent outcomes. J Nutr Therapeutics. 2012;1:59–73.
6.
go back to reference Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, et al. IBD around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the world digestive health day 2010: Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis. 2011;17:639–44.CrossRefPubMed Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, et al. IBD around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the world digestive health day 2010: Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis. 2011;17:639–44.CrossRefPubMed
7.
go back to reference Loftus CG, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton 3rd LJ, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–61.CrossRefPubMed Loftus CG, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton 3rd LJ, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–61.CrossRefPubMed
8.
go back to reference Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58(5):1322–8.CrossRefPubMed Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58(5):1322–8.CrossRefPubMed
9.
go back to reference Joachim G. Responses of people with inflammatory bowel disease to foods consumed. SGNA. 2000;23(4):160–7. Joachim G. Responses of people with inflammatory bowel disease to foods consumed. SGNA. 2000;23(4):160–7.
10.
go back to reference Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4:1095–119.CrossRefPubMedPubMedCentral Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4:1095–119.CrossRefPubMedPubMedCentral
11.
go back to reference Esteve C, Ramirez M, Fernández Bañares F, Abad-Lacruz A, Gil A, Cabré E, et al. Determinants of plasma fatty acid abnormalities in patients with active inflammatory bowel disease: a multivariate analysis. Inflamm Bowel Dis. 1995;1(2):95–100. Esteve C, Ramirez M, Fernández Bañares F, Abad-Lacruz A, Gil A, Cabré E, et al. Determinants of plasma fatty acid abnormalities in patients with active inflammatory bowel disease: a multivariate analysis. Inflamm Bowel Dis. 1995;1(2):95–100.
12.
13.
go back to reference Cooney JM, Barnett MPG, Brewster D, Knoch B, McNabb WC, Laing WA, et al. Proteomic analysis of colon tissue from Interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis. J Proteome Res. 2012;11:1065–77.CrossRefPubMed Cooney JM, Barnett MPG, Brewster D, Knoch B, McNabb WC, Laing WA, et al. Proteomic analysis of colon tissue from Interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis. J Proteome Res. 2012;11:1065–77.CrossRefPubMed
14.
go back to reference Mañé J, Pedrosa E, Lorén V, Ojanguren I, Fluvià L, Cabré E, et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in Interleukin-10–deficient Mice. J Nutr. 2009;139:603–10.CrossRefPubMed Mañé J, Pedrosa E, Lorén V, Ojanguren I, Fluvià L, Cabré E, et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in Interleukin-10–deficient Mice. J Nutr. 2009;139:603–10.CrossRefPubMed
15.
go back to reference James MJ, Gibson RA, Clel LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71:343S–8.PubMed James MJ, Gibson RA, Clel LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71:343S–8.PubMed
16.
go back to reference Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A. 2006;103:11276–81.CrossRefPubMedPubMedCentral Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A. 2006;103:11276–81.CrossRefPubMedPubMedCentral
17.
go back to reference Mbodjia K, Charpentiera C, Guérina C, Querec C, Bole-Feysot C, Aziz M, et al. Adjunct therapy of n-3 fatty acids to 5-ASA ameliorates inflammatory score and decreases NF-κB in rats with TNBS-induced colitis. J Nutr Biochem. 2013;24(4):700–5.CrossRef Mbodjia K, Charpentiera C, Guérina C, Querec C, Bole-Feysot C, Aziz M, et al. Adjunct therapy of n-3 fatty acids to 5-ASA ameliorates inflammatory score and decreases NF-κB in rats with TNBS-induced colitis. J Nutr Biochem. 2013;24(4):700–5.CrossRef
18.
go back to reference Yamamoto-Furusho JK, Jacintez-Cazares M, Furuzawa-Carballeda C. Peroxisome Proliferator-Activated Receptors family is involved in the response to treatment and mild clinical course in patients with Ulcerative Colitis. Dis Markers. 2014;2014:932530. doi: 10.1155/2014/932530.CrossRefPubMedPubMedCentral Yamamoto-Furusho JK, Jacintez-Cazares M, Furuzawa-Carballeda C. Peroxisome Proliferator-Activated Receptors family is involved in the response to treatment and mild clinical course in patients with Ulcerative Colitis. Dis Markers. 2014;2014:932530. doi: 10.1155/2014/932530.CrossRefPubMedPubMedCentral
19.
go back to reference Laing B, Han DY, Ferguson LR. Candidate genes involved in beneficial or adverse responses to commonly eaten erassica vegetables in a New Zealand Crohn’s disease cohort. Nutrients. 2013;5:5046–64.CrossRefPubMedPubMedCentral Laing B, Han DY, Ferguson LR. Candidate genes involved in beneficial or adverse responses to commonly eaten erassica vegetables in a New Zealand Crohn’s disease cohort. Nutrients. 2013;5:5046–64.CrossRefPubMedPubMedCentral
20.
go back to reference Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997;65:564–7.PubMed Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997;65:564–7.PubMed
21.
go back to reference Smith MA, Smith T, Trebble TM. Nutritional management of adults with inflammatory bowel disease: practical lessons from the available evidence. Frontline Gastroenterol. 2012;3:172–9.CrossRef Smith MA, Smith T, Trebble TM. Nutritional management of adults with inflammatory bowel disease: practical lessons from the available evidence. Frontline Gastroenterol. 2012;3:172–9.CrossRef
22.
go back to reference Fung QM, Szilagyi A. Carbohydrate elimination or adaptation diet for symptoms of intestinal discomfort in IBD: Rationales for “Gibsons’ Conundrum”. Int J Inflamm. 2012;2012:1–19.CrossRef Fung QM, Szilagyi A. Carbohydrate elimination or adaptation diet for symptoms of intestinal discomfort in IBD: Rationales for “Gibsons’ Conundrum”. Int J Inflamm. 2012;2012:1–19.CrossRef
23.
go back to reference Gearry RB, Irving PM, Barrett JS. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study. J Crohn's Colitis. 2009;3:8–14.CrossRef Gearry RB, Irving PM, Barrett JS. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study. J Crohn's Colitis. 2009;3:8–14.CrossRef
24.
go back to reference Olendzki BC, Silverstein TD, Persuitte GM. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:5.CrossRefPubMedPubMedCentral Olendzki BC, Silverstein TD, Persuitte GM. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:5.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire
Authors
Nallely Bueno-Hernández
Martha Núñez-Aldana
Ilse Ascaño-Gutierrez
Jesús K Yamamoto-Furusho
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2015
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/s12937-015-0014-3

Other articles of this Issue 1/2015

Nutrition Journal 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine